Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental HIV treatments

Gilead Files European Marketing Application for Boosting Agent Cobicistat

Editor's pick
Gilead press release
25 May 2012
Pharmaceutical industry

Mylan launches HIV-drug nevirapine in US

Editor's pick
pharmabiz.com
25 May 2012
Pharmaceutical industry

Who is really helping the WHO?

Editor's pick
Deutsche Welle
23 May 2012
Pharmaceutical industry

How CDC's hep.-C testing advice is already benefiting drugmakers

Editor's pick
Medical Marketing and Media
23 May 2012
Pharmaceutical industry

Prizes, Not Patents, For Drug Discovery?

Editor's pick
Pharmalot
22 May 2012
Pharmaceutical industry

EU drugs regulator accused of being too cozy with Big Pharma - Euro Parliament refuses to approve EMA accounts

Editor's pick
EU Observer
16 May 2012
New & experimental hepatitis C treatment

Achillion's hepatitis C drug gets FDA fast track

Editor's pick
Reuters
16 May 2012
Access to healthcare

Bernie Sanders floats plan to make HIV drugs less costly

Editor's pick
Politico
15 May 2012
PrEP

Debate rages over HIV drug

Editor's pick
Financial Times
14 May 2012
New & experimental HIV treatments

FDA Panel Endorses 'Quad' Pill for HIV

Editor's pick
MedPage Today HIV/AIDS
14 May 2012
PrEP

Pill to prevent HIV gets an FDA endorsement

Editor's pick
Los Angeles Times
11 May 2012
HIV treatment for children & young people

Drug Labels Often Lack Pediatric Information

Editor's pick
Pharmalot
11 May 2012
Opportunistic infections

FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes

Editor's pick
Medscape (requires registration)
11 May 2012
New & experimental HIV treatments

Gilead’s Quad Pill Raises Kidney Questions, FDA Says

Editor's pick
Bloomberg Business Week
9 May 2012
Access to healthcare

Dean Baker: Bernie Sanders Advocates a Free Market in AIDS Drugs

Editor's pick
Huffington Post
8 May 2012
New & experimental hepatitis C treatment

Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix

Editor's pick
The Street
8 May 2012
Neurological & cognitive problems

Pfizer Says Lyrica Fails in Diabetes Trial, Halts HIV Study

Editor's pick
Bloomberg
4 May 2012
Access to healthcare

Colombian Court: Abbott Labs' pricing abuse violated health rights

Editor's pick
Public Citizen
30 April 2012
PrEP

Truvada PrEP, Gilead, AHF's Bizarre Attack: Our Statement to the FDA

Editor's pick
AIDS Treatment News
30 April 2012
Pharmaceutical industry

Gilead Sciences 1Q profit down on Pharmasset costs

Editor's pick
CBS News
27 April 2012
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012